ETHICS OF VACCINATION AS THE CRITERIA OF THE SCIENTIFIC AND HUMANISTIC APPROACH

Código QR

ETHICS OF VACCINATION AS THE CRITERIA OF THE SCIENTIFIC AND HUMANISTIC APPROACH

.

Guardado en:

Detalles Bibliográficos
Autor principal:	O. I. Kubar
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/2a23c6d3a044489b9af85e283eb81c4f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

ETHICAL AND LEGAL ASPECTS OF INFECTOLOGY AND VACCINE PROPHYLAXIS. Part 1. Bioethics and social justice in infectious pathology
por: O. I. Kubar
Publicado: (2014)

ETHICAL AND LEGAL ASPECTS OF INFECTIOUS DISEASES AND VACCINATION. Part 2. Ethical aspects of planning and conducting of research in the field of vaccine prevention
por: O. I. Kubar, et al.
Publicado: (2014)

ETHICAL CONSIDERATION IN CONCEPTION OF INFECTIOUS DISEASES ERADICATION
por: O. I. Kubar, et al.
Publicado: (2018)

Ethical comments on COVID-19
por: O. I. Kubar
Publicado: (2020)

ETHICAL AND LEGAL ASPECTS OF INFECTIOUS DISEASES AND VACCINATION Part 3. Ethical principals of eradication of infectious diseases
por: O. I. Kubar, et al.
Publicado: (2014)

ETHICAL AND LEGAL ASPECTS OF INFECTIONS DISEASES AND VACCINATION Part 4. The balance between universal ethical and ecoethics principles on zooanthroponosis
por: O. I. Kubar, et al.
Publicado: (2015)

How overstated scientific claims undermine ethical principles in parenting interventions
por: Heidi Keller, et al.
Publicado: (2021)

ON THE TIMELINESS OF VACCINATION IN CHILDREN’S OUTPATIENT DEPARTMENT
por: A. A. Golubkova, et al.
Publicado: (2018)

COMPLIANCE OF HEALTH CARE WORKERS WITH VACCINATION AS THE FACTOR OF FORMATION OF POSITIVE ATTITUDE TOWARDS VACCINATION IN THE POPULATION
por: T. A. Platonova, et al.
Publicado: (2018)

Using scientific authorship criteria as a tool for equitable inclusion in global health research
por: Seye Abimbola, et al.
Publicado: (2021)

HLA GENE POLYMORPHISM IN PERSONS VACCINATED AGAINST PLAGUE
por: O. M. Kudryavtseva, et al.
Publicado: (2018)

DEVELOPMENT OF PROTOTYPE OF UNIVERSAL INFLUENZA VACCINE BASED ON LIVE ATTENUATED INFLUENZA VACCINE VIRAL VECTOR
por: D. A. Mezhenskaia, et al.
Publicado: (2018)

IMMUNIZATION WITH UNIVERSAL INFLUENZA VACCINE ENHANCES IMMUNE RESPONSE TO SUBSEQUENT INFECTION
por: M. A. Shuklina, et al.
Publicado: (2018)

VACCINE PROPHYLAXIS, DIAGNOSTICS AND GENOTYPES OF MUMPS (EPIDEMIC PAROTITIS) VIRUS
por: N. V. Yuminova, et al.
Publicado: (2018)

MONITORING OF VACCINAL PROCESS IN HUMANS RESIDING IN THE ALTAI HIGH-MOUNTAINOUS NATURAL PLAGUE FOCUS
por: K. M. Korytov, et al.
Publicado: (2018)

MEASLES IN YEKATERINBURG: THE HISTORICAL PATH FROM THE PERIOD BEFORE VACCINATION TO THE STAGE OF ELIMINATION OF THE INFECTION
por: A. A. Golubkova, et al.
Publicado: (2018)

IMPROVEMENT OF TECHNOLOGY OF PRODUCTION OF HERPETIC VACCINE, CULTURAL, INACTIVE
por: G. S. Shitikova, et al.
Publicado: (2018)

No Jab, No Job? Ethical Issues in Mandatory COVID-19 Vaccination of Healthcare Personnel
por: Euzebiusz Jamrozik, et al.
Publicado: (2021)

EMERGENCE OF VACCINE-DERIVED POLIOVIRUSES DURING EBOL A VIRUS DISEASE OUTBREAK IN GUINEA, 2014–2015
por: M. D. Fernandez-Garcia, et al.
Publicado: (2018)

POTENTIAL INFLUENCE OF IMMUNOMODULATORS ON THE PRODUCTION OF INTERFERON-GAMMA AND INTERLEUKIN-10 IN LABORATORY ANIMALS VACCINATED AGAINST PLAGUE
por: A. Yu. Goncharova, et al.
Publicado: (2018)

SAPONIN TAUROSID Sx1 ADMINISTRATION ENHANCES ANTIBODY PRODUCTION IN MICE, CHALLENGED WITH INFLUENZA VIRUS OR IMMUNIZED WITH INFLUENZA GRIPPOL® VACCINE
por: V. Yu. Maligina, et al.
Publicado: (2018)

EVALUATION OF THE EFFECTIVENESS OF PNEUMOCOCCAL VACCINES FOR PREVENTION OF COMMUNITY-ACQUIRED PNEUMONIA IN SERVICEMEN
por: S. D. Zhogolev, et al.
Publicado: (2018)

CONTROL OF INFLUENZA VIA VACCINES: CHALLENGES AND PERSPECTIVES AS VIEWED BY VARIOUS STAKEHOLDERS
por: Y. M. Vasiliev
Publicado: (2018)

THE USE OF CORRELATION ANALYSIS ON THE EXAMPLE OF INFLUENZA VACCINATION ON THE TERRITORY OF THE ROSTOV REGION
por: S. S. Slis’, et al.
Publicado: (2018)

THE GRANULOCYTES PHAGOCYTIC CAPACITY TO YERSINIA PESTIS IN BLOOD SAMPLES OF ANTIPLAGUE VACCINATED PEOPLE ACCORDING TO FLOW CYTOMETRIC ANALYSIS DATA
por: A. L. Kravtsov, et al.
Publicado: (2018)

SONOCHEMICAL NANOSTRUCTURING OF ANTIBIOTICS IS A NEW APPROACH TO INCREASING THEIR EFFECTIVENESS AGAINST RESISTANT STRAINS
por: I. S. Kassirov, et al.
Publicado: (2018)

RISK FACTORS FOR SARI AND INFLUENZA VACCINE EFFECTIVENESS IN SENTINEL SURVEILLANCE SYSTEM IN RUSSIA, THE SEASON 2017–2018
por: E. A. Smorodintseva, et al.
Publicado: (2018)

Negative effect of the second dose of the BNT162b2 vaccine in a significant percentage of individuals with previous COVID infection
por: Elvira Baos, et al.
Publicado: (2022)

An Innovative Approach to Teaching Global Health Research Ethics
por: M. Withers, et al.
Publicado: (2017)

ENVIRONMENTAL AND HUMAN SURVEILLANCE OF POLIOVIRUSES AND OTHER ENTEROVIRUSES IN MADAGASCAR. IMPACT OF THE TRIVALENT TO BIVALENT ORAL POLIO VACCINE SWITCH
por: M.-L. Joffret, et al.
Publicado: (2018)

ANTI-PLAGUE VACCINATION STIMULATES THE NEUTROPHIL EXTRACELLULAR TRAPS FORMATION TO INCREASE THE YERSINIA PESTIS KILLING EFFICIENCY IN VIVO
por: A. L. Kravtsov, et al.
Publicado: (2018)

EVOLUTION OF THE VP1 REGION TYPE 2 VACCINE-DERIVED POLIOVIRUS SHEDDING FROM AN IMMUNOCOMPROMISED ALGERIAN CHILD
por: D. Boulahbal-Anes, et al.
Publicado: (2018)

A localised vasculitic-like skin rash following the second dose of COVID-19 vaccine
por: Anis Abobaker, et al.
Publicado: (2022)

THE ANALYSIS OF TRANSMITTED HIV-1 VARIANTS AMONG ACUTELY INFECTED PEOPLE WHO INJECT DRUGS USING NGS APPROACH
por: E. Akulova, et al.
Publicado: (2018)

Correction to: A formulated poly (I:C)/CCL21 as an effective mucosal adjuvant for gamma‑irradiated influenza vaccine
por: Ailar Sabbaghi, et al.
Publicado: (2021)

OPTIMIZATION OF EXPRESSION, PURIFICATION, AND STABILIZATION CONDITIONS FOR FLG-HA2-4M2E, A RECOMBINANT PROTEIN IN UNIVERSAL INFLUENZA VACCINE
por: A. A. Kovaleva, et al.
Publicado: (2018)

PATHOGENETIC TREATMENT OF SEVERE P. FALCIPARUM MALARIA: APPROACHES TO OPTIMIZATION
por: A. K. Tokmalayev, et al.
Publicado: (2018)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih Cucunawangsih, et al.
Publicado: (2021)

SIMPLIFYING NGS APPROACHES TO OPTIMIZE TRACING OF TRANSBORDER SPREAD OF MYCOBACTERIUM TUBERCULOSIS
por: D. Garcia de Viedma
Publicado: (2018)

Second ethical comments towards COVID-19 (one year later)
por: O. I. Kubar, et al.
Publicado: (2021)